Old Web
English
Sign In
Acemap
>
authorDetail
>
Charles Carrieri
Charles Carrieri
Pfizer
Diabetes mellitus
Cerebrospinal fluid
Pharmacology
Psychology
non clinical
2
Papers
33
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetic and pharmacodynamic effects of a γ‐secretase modulator, PF‐06648671, on CSF amyloid‐β peptides in randomized Phase 1 studies
2019
Clinical Pharmacology & Therapeutics
Jae Eun Ahn
Charles Carrieri
Fernando Dela Cruz
Terence Fullerton
Eva Hajos-Korcsok
Ping He
Constantino Kantaridis
Claire Leurent
Richann Liu
Jessica Y. Mancuso
Laure Mendes da Costa
Ruolun Qiu
Show All
Source
Cite
Save
Citations (11)
PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non-clinical species to healthy human volunteers
2009
Alzheimers & Dementia
Timothy Nicholas
Rebecca Evans
Scot Styren
Ruolun Qiu
Ellen Q. Wang
Frederick R. Nelson
Vu Le
Sarah Grimwood
Curt Christoffersen
Subhashis Banerjee
Brian Corrigan
Geralyn P. Kocan
Kieran F. Geoghegan
Charles Carrieri
Nancy Raha
Patrick Robert Verhoest
Holly Soares
Show All
Source
Cite
Save
Citations (22)
1